The Anticancer Potential of Kaempferol: A Systematic Review Based on In Vitro Studies

Everton Freitas de Morais1, Lilianny Querino Rocha de Oliveira1, Hannah Gil de Farias Morais2

  • 1Graduate Program in Oral Biology, Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba 13414-018, SP, Brazil.

Cancers
|February 10, 2024
PubMed

Insights

Kaempferol (KMP), a natural flavonoid, shows significant anticancer properties by inhibiting tumor growth, proliferation, and angiogenesis. It also enhances chemotherapy sensitivity, offering a promising therapeutic option for solid tumors.

Area of Science:

  • Oncology
  • Natural Products Chemistry
  • Molecular Biology

Background:

  • Cancer treatment faces challenges due to tumor heterogeneity.
  • Natural products, particularly flavonoids, show promise in cancer prevention and treatment.
  • Kaempferol (KMP) is a bioactive flavonoid with known anti-inflammatory, antioxidant, and anticancer properties.

Purpose of the Study:

  • To systematically review the therapeutic potential of kaempferol (KMP) against various solid malignant tumors.
  • To consolidate evidence on KMP's mechanisms of action in cancer.
  • To assess KMP's role in combination therapies.

Main Methods:

  • Systematic literature search following PRISMA guidelines across multiple databases (EMBASE, PubMed, Scopus, etc.).
  • Inclusion of 64 studies based on predefined selection criteria.
  • Analysis of in vitro data on KMP's effects on cancer cell behavior and molecular markers.

Main Results:

  • In vitro studies show KMP controls tumor cell cycle, proliferation, apoptosis, migration, and invasion.
  • Kaempferol inhibits angiogenesis and key markers of epithelial-mesenchymal transition.
  • KMP enhances cancer cell sensitivity to chemotherapy drugs like cisplatin and 5-fluorouracil.

Conclusions:

  • Kaempferol (KMP) demonstrates significant antitumor effects through multiple molecular pathways.
  • KMP is a promising therapeutic compound for solid tumors.
  • Combining KMP with existing anticancer agents may improve treatment efficacy and predictability.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K